Carla M Doyle
Overview
Explore the profile of Carla M Doyle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiu F, Doyle C, Doyle C, Anato J, Knight J, Wang L, et al.
Int J Infect Dis
. 2025 Jan;
153:107792.
PMID: 39848438
Objectives: The global mpox (clade II) outbreak of 2022 primarily affected gay, bisexual, and other men who have sex with men (GBM) and was met with swift community and public...
2.
Doyle C, Milwid R, Cox J, Xia Y, Lambert G, Tremblay C, et al.
J Int AIDS Soc
. 2023 Dec;
26(12):e26194.
PMID: 38054579
Introduction: HIV pre-exposure prophylaxis (PrEP) has been recommended and partly subsidized in Québec, Canada, since 2013. We evaluated the population-level impact of PrEP on HIV transmission among men who have...
3.
Milwid R, Li M, Fazil A, Maheu-Giroux M, Doyle C, Xia Y, et al.
J Med Virol
. 2023 Dec;
95(12):e29256.
PMID: 38054533
The 2022 mpox outbreak predominantly impacted gay, bisexual, and other men who have sex with men (gbMSM). Two models were developed to support situational awareness and management decisions in Canada....
4.
Stansfield S, Heitner J, Mitchell K, Doyle C, Milwid R, Moore M, et al.
J Int AIDS Soc
. 2023 Jul;
26 Suppl 2:e26109.
PMID: 37439080
Introduction: Long-acting injectable cabotegravir (CAB-LA) demonstrated superiority to daily tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for HIV pre-exposure prophylaxis (PrEP) in the HPTN 083/084 trials. We compared the potential impact of expanding...
5.
Doyle C, Cox J, Milwid R, Bitera R, Laniece Delaunay C, Alary M, et al.
J Int AIDS Soc
. 2022 Sep;
25(9):e25994.
PMID: 36050916
Introduction: Men who have sex with men (MSM) and people who inject drugs (PWID) are disproportionately impacted by the HIV epidemic in Canada. Having the second-highest provincial diagnosis rate, an...
6.
Milwid R, Xia Y, Doyle C, Cox J, Lambert G, Thomas R, et al.
BMC Infect Dis
. 2022 Mar;
22(1):233.
PMID: 35255860
Background: Gay, bisexual, and other men who have sex with men (gbMSM) experience disproportionate risks of HIV acquisition and transmission. In 2017, Montréal became the first Canadian Fast-Track City, setting...
7.
Doyle C, Maheu-Giroux M, Lambert G, Mishra S, Apelian H, Messier-Peet M, et al.
AIDS Behav
. 2020 Jul;
25(1):269-283.
PMID: 32648063
Pre-exposure prophylaxis (PrEP) became publicly available in Quebec for gay, bisexual and other men who have sex with men (GBM) in 2013. We used baseline data from Engage, a cohort...
8.
Maheu-Giroux M, Marsh K, Doyle C, Godin A, Laniece Delaunay C, Johnson L, et al.
AIDS
. 2019 Nov;
33 Suppl 3:S255-S269.
PMID: 31764066
Objective: HIV testing services (HTS) are a crucial component of national HIV responses. Learning one's HIV diagnosis is the entry point to accessing life-saving antiretroviral treatment and care. Recognizing the...
9.
Doyle C, Lix L, Hemmelgarn B, Paterson J, Renoux C
Pharmacoepidemiol Drug Saf
. 2019 Sep;
29 Suppl 1:68-77.
PMID: 31507029
Purpose: The Canadian Network for Observational Drug Effect Studies (CNODES) is a network of Canadian research centres using administrative data to conduct distributed drug safety and effectiveness studies. In this...
10.
Douros A, Durand M, Doyle C, Yoon S, Reynier P, Filion K
Drug Saf
. 2019 Jun;
42(10):1135-1148.
PMID: 31175610
Background: There are no head-to-head randomized controlled trials comparing different direct oral anticoagulants (DOACs). Thus, we systematically reviewed and meta-analyzed observational studies assessing the comparative effectiveness and safety of DOACs...